Validus Holdings, Ltd. (VR) Given Consensus Recommendation of “Hold” by Analysts

Shares of Validus Holdings, Ltd. (NYSE:VR) have been assigned an average recommendation of “Hold” from the eleven brokerages that are presently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $54.83.

A number of research analysts have issued reports on VR shares. Zacks Investment Research cut shares of Validus from a “hold” rating to a “strong sell” rating in a report on Thursday, September 28th. UBS decreased their price target on shares of Validus from $50.00 to $48.00 and set a “neutral” rating for the company in a report on Monday, October 2nd. TheStreet cut shares of Validus from a “b” rating to a “c+” rating in a report on Wednesday, October 11th. ValuEngine raised shares of Validus from a “sell” rating to a “hold” rating in a report on Friday, October 20th. Finally, BidaskClub cut shares of Validus from a “sell” rating to a “strong sell” rating in a report on Friday, August 18th.

Validus (VR) traded down $0.32 during midday trading on Thursday, hitting $46.16. 933,701 shares of the company’s stock were exchanged, compared to its average volume of 616,918. Validus has a fifty-two week low of $41.15 and a fifty-two week high of $58.76. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.95 and a quick ratio of 0.95.

Validus (NYSE:VR) last posted its quarterly earnings results on Thursday, October 26th. The insurance provider reported ($3.22) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($3.30) by $0.08. The business had revenue of $407.00 million during the quarter, compared to analysts’ expectations of $453.04 million. Validus had a negative net margin of 1.38% and a negative return on equity of 0.49%. The business’s quarterly revenue was up 24.3% on a year-over-year basis. During the same quarter last year, the company posted $1.02 earnings per share. equities analysts anticipate that Validus will post -0.24 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 29th. Investors of record on Friday, December 15th will be issued a dividend of $0.38 per share. The ex-dividend date is Thursday, December 14th. This represents a $1.52 annualized dividend and a dividend yield of 3.29%. Validus’s dividend payout ratio (DPR) is presently -233.84%.

In related news, President Kean Driscoll sold 6,875 shares of the firm’s stock in a transaction on Wednesday, November 15th. The shares were sold at an average price of $50.30, for a total transaction of $345,812.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Lixin Zeng sold 26,136 shares of the firm’s stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $52.10, for a total transaction of $1,361,685.60. Following the transaction, the chief executive officer now directly owns 57,855 shares of the company’s stock, valued at approximately $3,014,245.50. The disclosure for this sale can be found here. Company insiders own 2.33% of the company’s stock.

Institutional investors have recently modified their holdings of the stock. IFP Advisors Inc raised its holdings in shares of Validus by 14.0% during the second quarter. IFP Advisors Inc now owns 2,154 shares of the insurance provider’s stock worth $112,000 after purchasing an additional 265 shares during the last quarter. SG Americas Securities LLC purchased a new position in shares of Validus during the second quarter worth $116,000. Zions Bancorporation purchased a new position in shares of Validus during the third quarter worth $116,000. The Manufacturers Life Insurance Company grew its position in Validus by 10.1% during the second quarter. The Manufacturers Life Insurance Company now owns 2,382 shares of the insurance provider’s stock valued at $124,000 after buying an additional 219 shares during the period. Finally, BNP Paribas Arbitrage SA grew its position in Validus by 93.7% during the second quarter. BNP Paribas Arbitrage SA now owns 2,650 shares of the insurance provider’s stock valued at $138,000 after buying an additional 1,282 shares during the period. 96.35% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: “Validus Holdings, Ltd. (VR) Given Consensus Recommendation of “Hold” by Analysts” was first posted by Week Herald and is the sole property of of Week Herald. If you are accessing this story on another domain, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The legal version of this story can be accessed at https://weekherald.com/2017/12/14/validus-holdings-ltd-vr-given-consensus-recommendation-of-hold-by-analysts.html.

Validus Company Profile

Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.

Analyst Recommendations for Validus (NYSE:VR)

Receive News & Ratings for Validus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply